Furthermore, IGF-1 has been shown to stimulate cell survival pathways [34], [35] in vitro and in disease models such as subarachnoid hemorrhage [36], neonatal hypoxia ischemia [37] hippocampal trimethytin toxicity [38] and Parkinson’s disease [29]. This evidence concerns the gene IGF1 and subarachnoid hemorrhage.